Report Detail

Request for Sample of this report

North America Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country

RnM3599565
16 July, 2019
Global
249 Pages
The Insight Partners
Other

Drug delivery market in North America is expected to grow from US$ 572,452.95 Mn in the year 2018 and is expected to reach US$1,074,679.66 Mn by 2027 growing at a CAGR of 7.4% over the forecast period.
Driving factors such as a rising number of patients suffering from chronic diseases and increasing adoption of non-invasive drug delivery systems are likely to grow the drug delivery systems market in the forecast period. Whereas, the product recalls for these products are likely to impact the growth of the drug delivery systems market during the forecast period. On the other hand, the development of novel drug delivery solutions is likely to be a prevalent trend in the market. With the improvements in medical devices, and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via an alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore, these techniques are considered to be a preferred mode of drug delivery. The manufacturing cost may also be less for non-invasive dosage forms as compared to injections in many cases. For instance, inhaled insulin appears to be a non-invasive, well-tolerated, and liked modality of treatment of diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human) inhalation powder, which was approved by FDA. Thus, due to advantages offered by non-invasive drug delivery devices, the drug delivery systems market is expected to witness growth during the forecast period.
The North America drug delivery systems market on the basis of route of administration is segmented in to oral, transmucosal, injectable, topical, implantable and ocular. In 2018, the oral segment held the largest market share of 50.2% of the drug delivery systems market, by route of administration. The oral segment is expected to dominate its market share in 2027 owing to ease of drug administration, a high degree of flexibility on dosages and cost-effectiveness.
On the basis of application, the North America drug delivery systems market is segmented into hospitals & clinics, home care settings, and others. In 2018, the hospitals and clinics held the largest market share of 56.0% of the drug delivery systems market, by the application. This segment is also expected to dominate the market in 2027, owing to a large number of the patient population visiting hospitals and clinics. Also hospitals provide diagnosis and treatment for various medical conditions.
On the basis of the distribution channel, the North America drug delivery systems market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. In 2018, the hospitals pharmacies held the largest market share of 68.7% of the drug delivery systems market, by distribution channel. This segment is also expected to dominate the market in 2027 as hospital pharmacies provide a larger range of medications, including more specialized and investigational medications.
Some of the major primary and secondary sources for drug delivery systems included in the report are Centers of Disease Control & Prevention, Food and Drug Administration, World Health Organization and Others.

Part 1. Introduction

1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance

Part 2. North America Drug Delivery Systems Market – Key Takeaways

Part 3. North America Drug Delivery Systems Market – Market Landscape

3.1 Overview
3.2 Market Segmentation
- 3.2.1 North America Drug Delivery Systems Market – By Route Of Administration
- 3.2.2 North America Drug Delivery Systems Market – By Application
- 3.2.3 North America Drug Delivery Systems Market – By Distribution Channel
- 3.2.4 North America Drug Delivery Systems Market – By Country
3.3 PEST Analysis

Part 4. North America Drug Delivery Systems Market- Key Market Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Number Of Patients Suffering With Chronic Diseases
- 4.1.2 Increasing Adoption Towards Non-Invasive Drug Delivery Systems
4.2 Key Market Restraints
- 4.2.1 Product Recalls For Drug Delivery Systems
4.3 Key Market Opportunities
- 4.3.1 Rising Compliance Of Patients
4.4 Future Trends
- 4.4.1 Introduction Of Novel Drug Delivery Systems
4.5 Impact Analysis

Part 5. Drug Delivery Systems Market – North America Analysis

5.1 North America Drug Delivery Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players

Part 6. Drug Delivery Systems Market – North America Regulatory Scenario

6.1 North America
- 6.1.1 Us
- 6.1.2 Canada
- 6.1.3 Mexico

Part 7. North America Drug Delivery Systems Market Analysis – By Route Of Administration

7.1 Overview
7.2 North America Drug Delivery Systems Market, By Route Of Administration, 2018 & 2027 (%)
7.3 North America Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
7.4 Oral Drug Delivery Market
- 7.4.1 Overview
- 7.4.2 Oral Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
- 7.4.3 Solid Oral Drugs Market
  - 7.4.3.1 Overview
  - 7.4.3.2 Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.4.3.3 Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
- 7.4.4 Liquid Oral Drugs Market
  - 7.4.4.1 Overview
  - 7.4.4.2 Liquid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.4.4.3 Liquid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
- 7.4.5 Semi-Solid Oral Drugs Market
  - 7.4.5.1 Overview
  - 7.4.5.2 Semi-Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.4.5.3 Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
7.5 Transmucosal Drug Delivery Market
- 7.5.1 Overview
- 7.5.2 Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
- 7.5.3 Pulmonary Drug Delivery Market
  - 7.5.3.1 Overview
  - 7.5.3.2 Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.5.3.3 Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
  - 7.5.3.4 In-Metered Dose Inhalers Market
  - 7.5.3.4.1 Overview
  - 7.5.3.4.2 In-Metered Dose Inhalers Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.5.3.5 Dry Powder Inhalers Market
  - 7.5.3.5.1 Overview
  - 7.5.3.5.2 Dry Powder Inhalers Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.5.3.6 Nebulizers Market
  - 7.5.3.6.1 Overview
  - 7.5.3.6.2 Nebulizers Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.5.4 Nasal Drug Delivery Market
    - 7.5.4.1 Overview
    - 7.5.4.2 Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.4.3 Nasal Spray Market
    - 7.5.4.3.1 Overview
    - 7.5.4.3.2 Nasal Spray Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.4.4 Nasal Drops Market
    - 7.5.4.4.1 Overview
    - 7.5.4.4.2 Nasal Drops Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.4.5 Nasal Gel Market
    - 7.5.4.5.1 Overview
    - 7.5.4.5.2 Nasal Gel Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.5 Buccal Drug Delivery Market
      - 7.5.5.1 Overview
      - 7.5.5.2 Buccal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.6 Sublingual Drug Delivery Market
      - 7.5.6.1 Overview
      - 7.5.6.2 Sublingual Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.7 Rectal Transmucosal Drug Delivery Market
      - 7.5.7.1 Overview
      - 7.5.7.2 Rectal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.5.8 Vaginal Transmucosal Drug Delivery Market
      - 7.5.8.1 Overview
      - 7.5.8.2 Vaginal Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.6 Topical Drug Delivery Market
    - 7.6.1 Overview
    - 7.6.2 Topical Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.3 Semi-Solid Topical Drug Delivery Formulations Market
      - 7.6.3.1 Overview
      - 7.6.3.2 Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.4 Liquid Topical Drug Delivery Formulations Market
      - 7.6.4.1 Overview
      - 7.6.4.2 Liquid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.5 Solid Topical Drug Delivery Formulations Market
      - 7.6.5.1 Overview
      - 7.6.5.2 Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.6 Transdermal Patches Market
      - 7.6.6.1 Overview
      - 7.6.6.2 Transdermal Patches Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.7 Transdermal Gels Market
      - 7.6.7.1 Overview
      - 7.6.7.2 Transdermal Gels Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.6.8 Others Market
      - 7.6.8.1 Overview
      - 7.6.8.2 Others Market Revenue And Forecast To 2027 (US$ Mn)
  - 7.7 Injectable Drug Delivery Market
    - 7.7.1 Overview
    - 7.7.2 Injectable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.7.3 Conventional Injection Devices Market
      - 7.7.3.1 Overview
      - 7.7.3.2 Conventional Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
    - 7.7.4 Self-Injection Devices Market
      - 7.7.4.1 Overview
      - 7.7.4.2 Self-Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
      - 7.7.4.3 Needle Free Injectors Market
      - 7.7.4.3.1 Overview
      - 7.7.4.3.2 Needle Free Injectors Market Revenue And Forecast To 2027 (US$ Mn)
      - 7.7.4.4 Pen Injectors Market
      - 7.7.4.4.1 Overview
      - 7.7.4.4.2 Pen Injectors Market Revenue And Forecast To 2027 (US$ Mn)
      - 7.7.4.5 Wearable Injectors Market
      - 7.7.4.5.1 Overview
      - 7.7.4.5.2 Wearable Injectors Market Revenue And Forecast To 2027 (US$ Mn)
      - 7.8 Implantable Drug Delivery Market
        7.8.1 Overview
        7.8.2 Implantable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
        7.8.3 Active Implantable Market
        7.8.3.1 Overview
        7.8.3.2 Active Implantable Market Revenue And Forecast To 2027 (US$ Mn)
        7.8.4 Passive Implantable Market
        7.8.4.1 Overview
        7.8.4.2 Passive Implantable Market Revenue And Forecast To 2027 (US$ Mn)
      - 7.9 Ocular Drug Delivery Market
        7.9.1 Overview
        7.9.2 Ocular Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
        7.9.3 Eye Drops And Sprays Market
        7.9.3.1 Overview
        7.9.3.2 Eye Drops And Sprays Market Revenue And Forecast To 2027 (US$ Mn)
        7.9.4 Gels & Ointments Market
        7.9.4.1 Overview
        7.9.4.2 Gels & Ointments Market Revenue And Forecast To 2027 (US$ Mn)
        7.9.5 Ocular Inserts Market
        7.9.5.1 Overview
        7.9.5.2 Ocular Inserts Market Revenue And Forecast To 2027 (US$ Mn)
        7.9.6 Drug Coated Contact Lens Market
        7.9.6.1 Overview
        7.9.6.2 Drug Coated Contact Lens Market Revenue And Forecast To 2027 (US$ Mn)
        Part 8. North America Drug Delivery Systems Market Analysis – By Application
        8.1 Overview
        8.2 North America Drug Delivery Systems Market, By Application, 2018 & 2027 (%)
        8.3 North America Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
        8.4 Homecare Settings Market
        8.4.1 Overview
        8.4.2 North America Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
        8.5 Hospitals & Clinics Market
        8.5.1 Overview
        8.5.2 North America Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
        8.6 Others Market
        8.6.1 Overview
        8.6.2 North America Others Market Revenue And Forecasts To 2027 (US$ Mn)
        Part 9. North America Drug Delivery Systems Market Analysis – By Distribution Channel
        9.1 Overview
        9.2 North America Drug Delivery Systems Market, By Distribution Channel, 2018 & 2027 (%)
        9.3 North America Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
        9.4 Hospital Pharmacies Market
        9.4.1 Overview
        9.4.2 North America Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
        9.5 Retail Pharmacies Market
        9.5.1 Overview
        9.5.2 North America Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
        9.6 Online Pharmacies Market
        9.6.1 Overview
        9.6.2 North America Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
        Part 10. North America Drug Delivery Market
        10.1.1 Overview
        10.1.2 North America Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.3 North America Drug Delivery Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
        10.1.3.1 North America Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.2 North America Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.3 North America Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.4 North America Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.4.1 North America Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.5 North America Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.6 North America Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.7 North America Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.3.8 North America Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.4 North America Drug Delivery Market Revenue And Forecasts To 2027, By Application (US$ Mn)
        10.1.5 North America Drug Delivery Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
        10.1.6 North America Drug Delivery Market Revenue And Forecasts To 2027, By Country (%)
        10.1.7 US Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.8 US Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.8.1 US Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
        10.1.8.1.1 US Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.2 US Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.3 US Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.4 US Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.5 US Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.6 US Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.7 US Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.1.8 US Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.8.2 US Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
        10.1.8.3 US Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
        10.1.9 Canada Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.10 Canada Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.10.1 Canada Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
        10.1.10.1.1 Canada Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.2 Canada Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.3 Canada Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.4 Canada Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.5 Canada Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.6 Canada Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.7 Canada Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.8 Canada Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.1.9 Canada Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.10.2 Canada Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
        10.1.10.3 Canada Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
        10.1.11 Mexico Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.12 Mexico Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
        10.1.12.1 Mexico Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
        10.1.12.1.1 Mexico Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.2 Mexico Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.3 Mexico Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.4 Mexico Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.5 Mexico Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.6 Mexico Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.7 Mexico Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.8 Mexico Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.1.9 Mexico Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
        10.1.12.2 Mexico Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
        10.1.12.3 Mexico Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
        Part 11.Drug Delivery Systems Market – Industry Landscape
        11.1 Overview
        11.2 Comparative Company Analysis
        11.3 Growth Strategies Done By The Companies In The Market, (%)
        11.4 Organic Developments
        11.4.1 Overview
        11.5 Inorganic Developments
        11.5.1 Overview
        Part 12. Drug Delivery Systems Market–Key Company Profiles
        12.1 3M
        12.1.1 Key Facts
        12.1.2 Business Description
        12.1.3 Financial Overview
        12.1.4 Product Portfolio
        12.1.5 SWOT Analysis
        12.1.6 Key Developments
        12.2 BD
        12.2.1 Key Facts
        12.2.2 Business Description
        12.2.3 Financial Overview
        12.2.4 Product Portfolio
        12.2.5 SWOT Analysis
        12.2.6 Key Developments
        12.3 Boston Scientific Corporation
        12.3.1 Key Facts
        12.3.2 Business Description
        12.3.3 Financial Overview
        12.3.4 Product Portfolio
        12.3.5 SWOT Analysis
        12.3.6 Key Developments
        12.4 Novo Nordisk A/S
        12.4.1 Key Facts
        12.4.2 Business Description
        12.4.3 Financial Overview
        12.4.4 Product Portfolio
        12.4.5 SWOT Analysis
        12.4.6 Key Developments
        12.5 Bausch Health Companies Inc.
        12.5.1 Key Facts
        12.5.2 Business Description
        12.5.3 Financial Overview
        12.5.4 Product Portfolio
        12.5.5 SWOT Analysis
        12.5.6 Key Developments
        12.6 Baxter International, Inc.
        12.6.1 Key Facts
        12.6.2 Business Description
        12.6.3 Financial Overview
        12.6.4 Product Portfolio
        12.6.5 SWOT Analysis
        12.6.6 Key Developments
        12.7 Boehringer Ingelheim International GmbH
        12.7.1 Key Facts
        12.7.2 Business Description
        12.7.3 Financial Overview
        12.7.4 Product Portfolio
        12.7.5 SWOT Analysis
        12.7.6 Key Developments
        12.8 Novartis AG
        12.8.1 Key Facts
        12.8.2 Business Description
        12.8.3 Financial Information
        12.8.4 Product Portfolio
        12.8.5 SWOT Analysis
        12.8.6 Key Developments
        12.9 GlaxoSmithKline Plc.
        12.9.1 Key Facts
        12.9.2 Business Description
        12.9.3 Financial Overview
        12.9.4 Product Portfolio
        12.9.5 SWOT Analysis
        12.9.6 Key Developments
        12.10 Terumo Corporation
        12.10.1 Key Facts
        12.10.2 Business Description
        12.10.3 Financial Overview
        12.10.4 Product Portfolio
        12.10.5 SWOT Analysis
        12.10.6 Key Developments
        12.11 Johnson & Johnson Services, Inc.
        12.11.1 Key Facts
        12.11.2 Business Description
        12.11.3 Financial Overview
        12.11.4 Product Portfolio
        12.11.5 SWOT Analysis
        12.11.6 Key Developments
        Part 13. Appendix
        13.1 About The Insight Partners
        13.2 Glossary Of Terms
        13.3 Methodology
        13.3.1 Coverage
        13.3.2 Secondary Research

Europe Drug Delivery Systems Market Report

Asia Pacific Next Generation Sequencing Market Report

Summary:
Get latest Market Research Reports on North America Drug Delivery Systems. Industry analysis & Market Report on North America Drug Delivery Systems is a syndicated market report, published as North America Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country. It is complete Research Study and Industry Analysis of North America Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 16 July, 2019

1-User License	$3,000.00
Site License	$4,000.00
Enterprise License	$5,000.00

1-User License	2,313.00
Site License	3,084.00
Enterprise License	3,855.00

1-User License	2,778.00
Site License	3,704.00
Enterprise License	4,630.00

1-User License	459,720.00
Site License	612,960.00
Enterprise License	766,200.00

1-User License	252,990.00
Site License	337,320.00
Enterprise License	421,650.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Table Of Content

Part 1. Introduction

Part 2. North America Drug Delivery Systems Market – Key Takeaways

Part 3. North America Drug Delivery Systems Market – Market Landscape

Part 4. North America Drug Delivery Systems Market- Key Market Dynamics

Part 5. Drug Delivery Systems Market – North America Analysis

Part 6. Drug Delivery Systems Market – North America Regulatory Scenario

Part 7. North America Drug Delivery Systems Market Analysis – By Route Of Administration

Part 8. North America Drug Delivery Systems Market Analysis – By Application

Part 9. North America Drug Delivery Systems Market Analysis – By Distribution Channel

Part 10. North America Drug Delivery Market

Part 11.Drug Delivery Systems Market – Industry Landscape

Part 12. Drug Delivery Systems Market–Key Company Profiles

Part 13. Appendix

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter